Evidence map›Paper›PMID 41162391›Full record

ArticleScientific reports2025

Unveiling the phenylalanine coaggregation mechanism for a deep understanding of phenylketonuria disease.

Haruna L Barazorda-Ccahuana, Francesc Mas, Sergio Madurga

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haruna L Barazorda-CcahuanaComputational Biology and Chemistry Research Group, Universidad Católica de Santa María, Arequipa, 04000, Perú.
Francesc MasMaterials Science and Physical Chemistry Department & Research Institute of Theoretical and Computational Chemistry (IQTCUB), University of Barcelona, Barcelona, 08028, Spain.
Sergio MadurgaMaterials Science and Physical Chemistry Department & Research Institute of Theoretical and Computational Chemistry (IQTCUB), University of Barcelona, Barcelona, 08028, Spain. s.madurga@ub.edu.

Funding

Ministerio de Ciencia e Innovación CEX2021-001202-M
6 · The paper itself

Abstract

The abnormal accumulation of phenylalanine is a defining feature of phenylketonuria (PKU) and is Linked to the formation of toxic, amyloid-like fibrils. To investigate the molecular mechanisms underlying this aggregation, we performed all-atom molecular dynamics simulations of zwitterionic phenylalanine at physiological temperature. Systems with varying phenylalanine concentrations were simulated over 500 ns to assess aggregation dynamics, structural stability, and non-covalent interactions. Our results show that phenylalanine rapidly self-assembles into fibrillar structures stabilized by hydrogen bonding and π-π stacking. Higher concentrations led to more compact aggregates, as indicated by radial distribution functions and solvent-accessible surface area analyses. We further examined the coaggregation of alanine with phenylalanine fibrils and found that alanine preferentially binds to zwitterionic terminal regions via hydrogen bonds. This interaction may contribute to the enhanced toxicity of phenylalanine aggregates. These findings provide molecular-level insights into phenylalanine aggregation in PKU and support the development of strategies to mitigate its pathological effects.

Indexed as

PhenylalaninePhenylketonuriasAlanineAmyloidHumansHydrogen BondingMolecular Dynamics SimulationProtein AggregatesAlanineAmyloidPhenylalanineProtein Aggregates

Identifiers

PMID41162391
PMCPMC12572369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.